Recalls
Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.
Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means the agency’s own highest classification or reported deaths or serious injuries, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.
The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.
Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.
Minimum severity
Physicians Total Care is recalling Levothyroxine Tablets, USP, 0.175 mg, due to subpotency and stability issues. The recall affects specific lots distributed in Ohio and Georgia.
Watson Laboratories is recalling meprobamate 200 mg tablets because an impurity, diphenyl sulfone, exceeded specification limits.
Hospira Inc. is recalling 567,624 bags of Metronidazole Injection due to a potential leak that compromises sterility.
Watson Laboratories is recalling meprobamate 400 mg tablets because an impurity, diphenyl sulfone, exceeded specification limits.
Watson Laboratories is recalling Zarah oral contraceptive tablets because they may break while being pushed through the blister pack.
Novartis Consumer Health is recalling Myoflex Pain Relieving Cream because lot numbers and expiration dates may be illegible. The recall covers 2-oz and 4-oz tubes distributed nationwide and in Panama.
Novartis Consumer Health is recalling Nupercainal Ointment because lot numbers and expiration dates may be illegible or missing.
Novartis Consumer Health is recalling 4 Way Nasal Spray because lot numbers and expiration dates may be illegible.
Novartis Consumer Health is recalling 4 way Nasal Decongestant Menthol Nasal Spray because lot numbers and expiration dates may be illegible.
Novartis Consumer Health is recalling 4 Way Saline Moisturizing Mist bottles because lot numbers or expiration dates may be illegible or missing.
West-ward Pharmaceutical Corp. is recalling 1,763 bottles of Carisoprodol Tablets, 350 mg, because they lack the required C-IV imprint on the label.
RX3 Pharmacy is recalling 126 vials of Medi-bolic Booster Injectable because the product was not manufactured according to Good Manufacturing Procedures.
A B Nutrition, Inc. is recalling 509 bottles of Piracetam Powder marketed as a dietary supplement because it is an unapproved new drug.
Humco Holding Group is recalling Mercuroclear Antiseptic Anesthetic First Aid products due to potential contamination with Burkholderia gladioli. The recall covers 1,269,846 bottles distributed nationwide.
A B Nutrition, Inc. is recalling 2,980 bottles of Piracetam dietary supplement because it is an unapproved new drug marketed without an approved NDA or ANDA.
A B Nutrition, Inc. is recalling 912 bottles of Aniracetam dietary supplement because it is an unapproved new drug marketed without an approved NDA or ANDA.
K C Pharmaceuticals is recalling 31,704 bottles of Eye Drops advanced relief because the back labels fail to list three active ingredients.
Teva Pharmaceuticals USA is recalling specific lots of Terazosin Hydrochloride Capsules because a foreign capsule was found in one bottle.
Fresenius Kabi USA LLC is recalling 155,900 vials of Calcium Glucosate Injection, USP, 10% due to missing labels. The recall is nationwide.
AstraZeneca is recalling Pulmicort Respules because the budesonide concentration may be slightly above or below the specification range.
AstraZeneca is recalling PULMICORT RESPULES because the budesonide content may be slightly above or below the specification range.
Hospira is recalling 11,412 bags of HEXTEND (Hetastarch) 6% Injection due to a potential leak from the fill tube seal that compromises sterility.
Hospira Inc. is recalling 325,056 bags of 0.9% Sodium Chloride Injection USP, 100 mL, due to a potential lack of assurance of sterility.
Actavis Elizabeth LLC is recalling 9,264 bottles of amphetamine extended-release capsules because the product failed to meet dissolution specifications.
Bristol Myers Squibb is recalling specific Abilify 30 mg tablets because rejected material was inadvertently shipped. The affected product was distributed in LA, TN, and CA.